Label Image (Lbl504369121)
Sildenafil
Product Images NDC 50436-9121
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Sildenafil (NDC 50436-9121). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Unit Dose Services, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure-10 (Sildenafil Fig 10)
Figure-11 (Sildenafil Fig 11)
Fig-12 (Sildenafil Fig 12)
Fig-6 (Sildenafil Fig 6)
Fig-8 (Sildenafil Fig 8)
This is a table showing drugs and their recommended Fold Change and 90% CI Interaction. The table includes drug names, recommended dose adjustments, and whether a dose adjustment is needed or not. It also includes a chart that shows the change relative to the interacting drug alone with vertical solid lines at x= 1 for different combinations of drugs. There is also a note regarding the effect of one drug on the PK of another drug.*
Figure-9 (Sildenafil Fig 9)
Figure-7 (Sildenafil Figure 7)
This text appears to be a drug interaction chart showing the effects of various drugs on the absorption and metabolism of Atorvastatin, Astromycin, Bosentan, Cimetidine, Everolimus, and Saquinavir. It indicates whether each drug requires a dose adjustment or not. The chart also includes a graph with a solid line at x=1, showing a relative change to Sildenafil alone. The text mentions that there is no benefit on exercise capacity when sildenafil is added to bosentan therapy.*
Str (Sildenafil Str)
Not available.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
